Hunan Jingfeng Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 376.81 million compared to CNY 395.86 million a year ago. Revenue was CNY 380.52 million compared to CNY 402.01 million a year ago.

Net loss was CNY 12.85 million compared to CNY 11.46 million a year ago. Basic loss per share from continuing operations was CNY 0.0146 compared to CNY 0.013 a year ago. Diluted loss per share from continuing operations was CNY 0.0146 compared to CNY 0.013 a year ago.